These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chemotherapy of the recurrence of tumors of the gastrointestinal system]. Holdener EE Chirurg; 1985 Aug; 56(8):503-8. PubMed ID: 4042767 [No Abstract] [Full Text] [Related]
4. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma. Trux F Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880 [No Abstract] [Full Text] [Related]
5. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. Cersosimo RJ; Hong WK J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for gastrointestinal malignancy. Van der Veer LD; Balint JA Am J Gastroenterol; 1980 Jul; 74(1):40-9. PubMed ID: 7424879 [TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of cis-diamminedichloroplatinum (CDDP) and 5-fluorouracil (5-FU) in gastrointestinal tumors]. Yamazaki H; Ogawa M; Horikoshi N; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T; Miyaoka K Gan To Kagaku Ryoho; 1986 Aug; 13(8):2568-72. PubMed ID: 3017230 [TBL] [Abstract][Full Text] [Related]
8. Systemic chemotherapy for advanced gastrointestinal cancer. Bedikian AY; Valdivieso M; Bodey GP South Med J; 1980 Aug; 73(8):1046-52. PubMed ID: 6996103 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of gastrointestinal tumors (review of the literature)]. Mayr AC Onkologie; 1978 Dec; 1(6):248-56. PubMed ID: 83561 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and cancer of the gastrointestinal tract. Terz JJ; Beatty JD Surg Annu; 1979; 11():149-80. PubMed ID: 388686 [TBL] [Abstract][Full Text] [Related]
11. Systemic cytostatic drug therapy in liver cancer. Glimelius B Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989 [No Abstract] [Full Text] [Related]
13. [Gastrointestinal tumors. Prognostic factors and chemotherapy of today]. Joss R; Goldhirsch A; Tschopp L; Brunner K Dtsch Med Wochenschr; 1981 Dec; 106(49):1664-9. PubMed ID: 7308009 [No Abstract] [Full Text] [Related]
14. Clinical strategies in the chemotherapy of gastrointestinal cancer. Macdonald JS; Woolley PV; Schein PS Recent Results Cancer Res; 1980; 70():179-85. PubMed ID: 6986641 [TBL] [Abstract][Full Text] [Related]
15. Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumors. Adenis A; Leriche N; Pion JM; Vanlemmens L; Bonneterre J Anticancer Res; 1996; 16(4A):2063-7. PubMed ID: 8712743 [TBL] [Abstract][Full Text] [Related]
16. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer. Kolarić K; Potrebica V; Stanovnik M Oncology; 1986; 43(2):73-7. PubMed ID: 3513075 [TBL] [Abstract][Full Text] [Related]
17. Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas. Sun W; Metz JM; Gallagher M; O'Dwyer PJ; Giantonio B; Whittington R; Haller DG Cancer Chemother Pharmacol; 2011 Mar; 67(3):621-7. PubMed ID: 20495918 [TBL] [Abstract][Full Text] [Related]